These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 405754

  • 1. Cidal and subcidal effect of triethylene thiophosphoramide on cell kinetics of human bladder carcinoma cells in vitro.
    Kato T, Irwin RJ.
    Tohoku J Exp Med; 1977 Apr; 121(4):391-400. PubMed ID: 405754
    [Abstract] [Full Text] [Related]

  • 2. Changes of cell cycle affecting cidal effect of triethylene thiophosphoramide on cultured human bladder carcinoma cells.
    Kato T, Ishikawa K, Nemoto R, Irwin RJ.
    Tohoku J Exp Med; 1978 Jun; 125(2):163-7. PubMed ID: 99842
    [Abstract] [Full Text] [Related]

  • 3. [Cell kinetics of the bladder carcinoma. III. Changes of the cell cycle following thio-TEPA treatment and possible factors for kinetics of cell killing in cultured human bladder carcinoma cells (author's transl)].
    Kato T, Ishikawa K, Nemoto R.
    Nihon Hinyokika Gakkai Zasshi; 1977 Nov; 68(11):1029-35. PubMed ID: 415167
    [No Abstract] [Full Text] [Related]

  • 4. Cellular pharmacology of N,N',N''-triethylene thiophosphoramide.
    Miller B, Tenenholz T, Egorin MJ, Sosnovsky G, Rao NU, Gutierrez PL.
    Cancer Lett; 1988 Aug 15; 41(2):157-68. PubMed ID: 3135933
    [Abstract] [Full Text] [Related]

  • 5. [Enhanced cell killing by thio-TEPA and urokinase (author's transl)].
    Taya T.
    Nihon Hinyokika Gakkai Zasshi; 1979 Jan 15; 70(1):15-27. PubMed ID: 107356
    [No Abstract] [Full Text] [Related]

  • 6. [Cell kinetics of the bladder carcinoma. II. Effects of thio-TEPA on proliferative kinetics of the cultured human bladder carcinoma cells (author's transl)].
    Kato T.
    Nihon Hinyokika Gakkai Zasshi; 1976 Jul 20; 67(7):497-501. PubMed ID: 823357
    [No Abstract] [Full Text] [Related]

  • 7. ADJUVANT CHEMOTHERAPY (TRIETHYLENE THIOPHOSPHORAMIDE) WITH RADICAL MASTECTOMY AND RADIOTHERAPY IN BREAST CANCER.
    HANKINS GW, MCCARTEN AB.
    Can Med Assoc J; 1963 Dec 28; 89(26):1305-9. PubMed ID: 14101448
    [Abstract] [Full Text] [Related]

  • 8. Preclinical studies relating to the use of thiotepa in the high-dose setting alone and in combination.
    Teicher BA, Holden SA, Eder JP, Herman TS, Antman KH, Frei E.
    Semin Oncol; 1990 Feb 28; 17(1 Suppl 3):18-32. PubMed ID: 2106164
    [Abstract] [Full Text] [Related]

  • 9. Enhanced lethality by methylxanthines in human bladder cancer cells treated with thiotepa.
    Fingert HJ, Kindy RL, Pardee AB.
    J Urol; 1984 Sep 28; 132(3):609-13. PubMed ID: 6433047
    [Abstract] [Full Text] [Related]

  • 10. Verapamil enhanced in vitro chemosensitivity of a murine bladder carcinoma, FCB.
    Ballou RJ, Simpson WG, Harty JI, Tseng MT.
    Urol Res; 1986 Sep 28; 14(4):195-200. PubMed ID: 3097900
    [Abstract] [Full Text] [Related]

  • 11. Estimation of cell damage in monolayer culture using 14C-leucine incorporation.
    Kato T, Ishikawa K, Nemoto R.
    Tohoku J Exp Med; 1977 Apr 28; 121(4):403-4. PubMed ID: 405755
    [Abstract] [Full Text] [Related]

  • 12. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GR.
    J Urol; 1978 Jan 28; 119(1):59-61. PubMed ID: 413937
    [Abstract] [Full Text] [Related]

  • 13. Morphologic effects of thio-TEPA on mammalian urothelium. Changes in abnormal cells.
    Murphy WM, Soloway MS, Lin CJ.
    Acta Cytol; 1978 Jan 28; 22(6):550-4. PubMed ID: 104512
    [Abstract] [Full Text] [Related]

  • 14. Verapamil enhancement of chemotherapeutic efficacy in human bladder cancer cells.
    Simpson WG, Tseng MT, Anderson KC, Harty JI.
    J Urol; 1984 Sep 28; 132(3):574-6. PubMed ID: 6433043
    [Abstract] [Full Text] [Related]

  • 15. Protection of mammalian cells against chemotherapeutic agents thiotepa, 1,3-N,N'-bis(2-chloroethyl)-N-nitrosourea, and mafosfamide using the DNA base excision repair genes Fpg and alpha-hOgg1: implications for protective gene therapy applications.
    Xu Y, Hansen WK, Rosenquist TA, Williams DA, Limp-Foster M, Kelley MR.
    J Pharmacol Exp Ther; 2001 Mar 28; 296(3):825-31. PubMed ID: 11181913
    [Abstract] [Full Text] [Related]

  • 16. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
    Knuchel R, Hofstadter F, Jenkins WE, Masters JR.
    Cancer Res; 1989 Mar 15; 49(6):1397-401. PubMed ID: 2493980
    [Abstract] [Full Text] [Related]

  • 17. Treatment of malignant brain tumors with alkylating agents. Thio-TEPA (triethylene thiophosphoramide): its differential concentration and toxicity after arterial infusion.
    MARK VH, KJELLBERG RN, OJEMANN RG, SOLOWAY AH.
    Neurology; 1960 Aug 15; 10():772-6. PubMed ID: 14421240
    [No Abstract] [Full Text] [Related]

  • 18. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E, Zitron S, Nissenkorn I, Servadio C.
    Isr J Med Sci; 1980 Aug 15; 16(9-10):714-6. PubMed ID: 6776072
    [Abstract] [Full Text] [Related]

  • 19. SOME OBSERVATIONS ON THE CHEMOTHERAPEUTIC PALLIATION OF INOPERABLE PRIMARY CARCINOMA OF THE OVARY USING TRIETHYLENE THIOPHOSPHORAMIDE.
    SINCLAIR WY.
    Br J Clin Pract; 1964 Apr 15; 18():195-8. PubMed ID: 14140729
    [No Abstract] [Full Text] [Related]

  • 20. Intravesical thio-tepa: a study of 3H-thymidine uptake in normal urothelium and FANFT-induced tumors in rats.
    Nieh PT, Daly JJ, Irwin RJ, Prout GR.
    Invest Urol; 1979 May 15; 16(6):486-8. PubMed ID: 109416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.